Le Lézard
Classified in: Health, Business
Subjects: PER, LIC

ANNE THERESE AESTHETIC MEDICINE JOINS ALPHA AESTHETICS PARTNERS


SACRAMENTO, Calif., Jan. 30, 2024 /PRNewswire/ -- Alpha Aesthetics Partners, a Thurston Group portfolio company, is thrilled to announce its partnership with Anne Therese Aesthetic Medicine, a leading medical aesthetics practice with two locations in Columbus, Ohio, and an additional office in Cape Coral, Florida.

Founded and led by Dr. Anne Therese Stubbs, who has nearly 20 years of industry experience and is board-certified in aesthetic medicine, Anne Therese Aesthetic Medicine has established a reputation for delivering high-quality treatments and providing patient-centered care. As an active member of the American Academy of Cosmetic Surgery and a faculty member for ZO Skin Health and Galderma, Dr. Stubbs has been instrumental in training and educating hundreds of injectors across the United States. This partnership underscores a mutual commitment to excellence in clinical care and enhancing the patient experience.

The collaboration with Anne Therese Aesthetic Medicine enables Alpha Aesthetics Partners to further its commitment to providing best-in-class support and resources to medical spas. By joining forces, Alpha Aesthetics Partners strengthens its industry presence, combining the extensive network and resources of a national brand with the distinctive expertise and personalized approach of Anne Therese Aesthetic Medicine. This partnership represents a strategic move toward growth and enhanced service in the dynamic field of aesthetic medicine.

Dr. Anne Therese Stubbs shared her vision for the partnership, stating, "In the fast-evolving field of aesthetic medicine, staying ahead is crucial. Partnering with Alpha allows us to collaborate with top experts nationwide, elevating our training and patient experience. This step aligns with our core values of providing exceptional care and outcomes. Joining Alpha connects us with industry leaders, enhancing our practice and benefiting our patients."

John Wheeler, CEO of Alpha Aesthetics Partners, shared his perspective on the new collaboration, stating, "It is a privilege to welcome Dr. Anne Therese Stubbs and her team into our network. Dr. Stubbs is a distinguished figure in aesthetic medicine, and her team is truly elite. Together, they represent a significant addition to Alpha Aesthetics Partners, enhancing our capacity to deliver the very best aesthetic care to our patients."

About Alpha Aesthetics Partners:
Alpha Aesthetics Partners, a fast-growing company in the medical aesthetics sector, is renowned for its unparalleled support and advanced clinical training. Led by industry experts, the company strategically partners with leading practices across the nation. It focuses on enhancing its operations and services, ensuring each practice retains its unique identity. Alpha Aesthetics Partners' commitment to quality and progressive growth has established it as a significant player in the medical aesthetics industry.

About Anne Therese Aesthetic Medicine:
Anne Therese Aesthetic Medicine (ATAM), founded by Dr. Anne Therese Stubbs, serves the medical aesthetics needs of patients in Columbus, Ohio, and Cape Coral, Florida. Renowned for its focus on high-quality treatments and patient care, ATAM stands out in the aesthetic medicine field. Dr. Stubbs, a board-certified physician, specializes in minimally invasive procedures, ensuring a patient-first approach in all treatments.

Media Contact:
John Wheeler
CEO
Alpha Aesthetics Partners
partnerwithalpha.com
[email protected]
916-549-2233

SOURCE Alpha Aesthetics Partners


These press releases may also interest you

30 jun 2024
SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...

30 jun 2024
"AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New...

30 jun 2024
"AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New...

30 jun 2024
On June 27, 2024, Yidu Tech Inc. (the ''Company'' or ''Yidu Tech'') (2158.HK), a leader in China's AI medical industry, announced its results for the 2024 fiscal year. During the reporting period, the Company recorded revenue of RMB 807.1 million....

30 jun 2024
Yidu Tech Inc. ("Yidu Tech" or the "Company", together with its subsidiaries and consolidated affiliated entities, the "Group", HKEX: 2158) announced its annual results for the fiscal year ended 31 March 2024 ("FY2024" or the "Reporting Period"). The...

30 jun 2024
CBC Group ("CBC"), Asia's largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its controlled portfolio company, Hasten Biopharmaceutical ("Hasten"), an innovation-driven biopharmaceutical company, has...



News published on and distributed by: